Edition:
United States

People: Bristol-Myers Squibb Co (BMYMP.PK)

BMYMP.PK on OTC Markets Group

1,050.00USD
--
Change (% chg)

-- (--)
Prev Close
$1,050.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
17
52-wk High
$1,100.00
52-wk Low
$788.70

Caforio, Giovanni 

Dr. Giovanni Caforio M.D., is Chairman of the Board, Chief Executive Officer of the Company., Effective May 02 2017. He has been our Chief Executive Officer since May 2015 and our Chairman-Designate since December 2016. He was our Chief Operating Officer from June 2014 to May 2015, and he served as Executive Vice President and Chief Commercial Officer from November 2013 to June 2014. From October 2011 to November 2013, he served as President, U.S. Dr. Caforio held the position of Senior Vice President, Global Commercialization and Immunology from May 2010 to October 2011. Prior to that, he served as Senior Vice President, Oncology, U.S. and Global Commercialization from March 2009 to May 2010. From January 2007 to March 2009 he served as Senior Vice President, U.S. Oncology and from May 2004 to January 2007, he served as Senior Vice President, European Marketing and Brand Commercialization. Dr. Caforio is a member of the Board of Trustees of Hun School of Princeton and the Pharmaceutical Research and Manufacturers of America.

Basic Compensation

Total Annual Compensation, USD 4,508,920
Restricted Stock Awards, USD 11,823,800
Long-Term Incentive Plans, USD --
All Other, USD 601,134
Fiscal Year Total, USD 16,933,900

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 70,580 3,168,360.00
Name Fiscal Year Total

Giovanni Caforio

16,933,900

Charles Bancroft

6,971,690

Louis Schmukler

--

Ann Judge

--

Thomas Lynch

322,500

Sandra Leung

5,441,800
As Of  30 Dec 2016